ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
9 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
447
|
130K
|
9
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
71 |
26K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
71
|
26K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Weazel
|
86 |
28K |
7 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
86
|
28K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
OARSI 2024
|
|
Weazel
|
86 |
28K |
18 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
86
|
28K
|
18
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
6 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
71 |
26K |
3 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
71
|
26K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
4.8K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
18
|
4.8K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
447
|
130K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
4.8K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
18
|
4.8K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
447
|
130K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Annual Report to Shareholders
|
|
Weazel
|
18 |
4.8K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
18
|
4.8K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
8 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
6
|
|
ASX - By Stock
|
BTH |
Re:
BTH
|
|
Weazel
|
268 |
81K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
268
|
81K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Q4 2023 Investor Presentation
|
|
Weazel
|
71 |
26K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
71
|
26K
|
3
|
|
ASX - By Stock
|
WDS |
Re:
Woodside
|
|
Weazel
|
1.0K |
416K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.0K
|
416K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
2x2 Yay Or Nay From The FDA?
|
|
Weazel
|
13 |
4.1K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
13
|
4.1K
|
1
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Weazel
|
29 |
8.7K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
29
|
8.7K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
233 |
81K |
1 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
233
|
81K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
233 |
81K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
233
|
81K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
233 |
81K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
233
|
81K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Type D Response Submitted and Received by the US FDA
|
|
Weazel
|
46 |
15K |
12 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
46
|
15K
|
12
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
233 |
81K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
233
|
81K
|
0
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
10 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Weazel
|
233 |
81K |
0 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
233
|
81K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Weazel
|
29 |
8.7K |
13 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
29
|
8.7K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
6 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
369 |
127K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
369
|
127K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
447
|
130K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
447
|
130K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
4 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
447
|
130K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Weazel
|
4.2K |
3.7M |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
4.2K
|
3.7M
|
4
|
|
ASX - By Stock
|
BTH |
Re:
Ann: Half Year FY24 Results Presentation
|
|
Weazel
|
35 |
11K |
0 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
35
|
11K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
447
|
130K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
1 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
447
|
130K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
3 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
447
|
130K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
0 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
447
|
130K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
447
|
130K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Weazel
|
2.7K |
643K |
11 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
2.7K
|
643K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
447
|
130K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
Weazel
|
447 |
130K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
447
|
130K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
369 |
127K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
127K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Weazel
|
369 |
127K |
10 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
369
|
127K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Weazel
|
160 |
47K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
160
|
47K
|
4
|
|